Fall 2023 Vol. 13 Issue 03
-
From the Editor-in-Chief
Immunotherapy Gets Personal
Therapeutic vaccines can stimulate an immune response to cancer.
by William G. Nelson, MD, PhD
-
Your Cancer Guide
The Art of Deflection
Casual conversations can take unwelcome turns after you’ve been diagnosed with cancer. Here’s how to respond when people say the wrong things.
by Hester Hill Schnipper
-
Caregiving With Confidence
Addressing Anger
Caregivers can take steps to encourage patients to have more healthy dialogue about strong emotions.
by K.J. Bannan
-
Policy Matters
Clinical Trials That Reflect Real-world Patients
A recent article discusses challenges and practical solutions for working toward more diverse and equitable oncology clinical trials.
by Nicholas Warren, PhD
-
Immunotherapy: When Is Sooner Better Than Later?
Researchers explore whether giving immunotherapy before surgery and other treatments could improve outcomes for people with cancer.
by Stephen Ornes
-
Living With Chronic Blood Cancer
Thanks to medical advances, more people with blood cancer are living for years or even decades after their diagnosis. But when these diseases are incurable, patients must learn to adjust to ongoing monitoring and treatment.
by Kendall K. Morgan
-
Making Clinical Trials Easier
Clinical trials can be hard to find, challenging to get into and difficult to complete. Patient advocates and their supporters want to change that.
by Cameron Walker
-
Survivor Profile
Changing Course
Initially diagnosed with ductal carcinoma in situ, Sabrina Mayhew’s persistence in seeking out experts would lead to tumor testing that indicated she could safely forgo chemotherapy.
by Queen Muse
-
Q&A
Pulling Back the Research Curtain
Jessica Wapner looks back on the scientific discoveries that transformed outcomes for chronic myelogenous leukemia.
by Marci A. Landsmann
-
Get Involved
A Bountiful Harvest
Food for the Cure provides fresh produce to people with cancer.
by Thomas Celona
-
Facts and Stats
Will We Make the Moonshot?
As the Cancer Moonshot aims to cut cancer deaths in half by 2047, researchers identify strategies to hit that benchmark.
by Thomas Celona
Cancer Talk
Evidence grows that some people with HER2-positive breast cancer may do well on HER2-targeted therapy alone.
by Myles Starr
Germline Genetic Testing Lags Behind GuidelinesLow rates of germline genetic testing in cancer patients means information that could affect treatment isn’t available.
by Jon Kelvey
Progress in Lung CancerNovember is Lung Cancer Awareness Month. Here are stories describing lung cancer treatment advances and the experiences of people who have been through a diagnosis.
Against All OddsAt age 26, Manny Garcia was diagnosed with and fought pancreatic cancer.
by Karon Warren